• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Moderna, Inc. - Common Stock (NQ:MRNA)

    68.27 -8.29 (-10.83%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Moderna, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    News headline image
    You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500. ↗
    Could this player be heading into a new era of growth? 
    Via The Motley Fool
    Topics Artificial Intelligence Economy Stocks
    News headline image
    Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026
    Via ACCESS Newswire
    News headline image
    2 S&P 500 Stocks with Exciting Potential and 1 We Ignore
    The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
    Via StockStory
    Topics Stocks
    News headline image
    Roivant and Immunovant Solidify Market Leadership as Brepocitinib and FcRn Programs Hit Critical Clinical Milestones
    The biotechnology sector witnessed a seismic shift this week as Roivant Sciences (Nasdaq: ROIV) and its subsidiary Immunovant (Nasdaq: IMVT) reported a series of clinical and regulatory updates that... 
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know
    What Happened? A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100% tariffs on imports of branded and pa... 
    Via StockStory
    Topics Government Stocks World Trade
    News headline image
    Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability
    As of March 31, 2026, Moderna Inc. (NASDAQ: MRNA) finds itself at a defining historical junction. After years of being defined by a single, world-altering product—its COVID-19 vaccine—the... 
    Via Finterra
    Topics Initial Public Offering
    News headline image
    Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know
    What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
    Via StockStory
    Topics Economy Government Stocks
    Stay informed with the top movers within the S&P500 index on Friday. ↗
    Via Chartmill
    These S&P500 stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    Corporate Fortress: S&P 500 Defies Gravity with Fifth Consecutive Quarter of Double-Digit Growth
    The American corporate engine has proven far more durable than even the most optimistic analysts predicted just a year ago. As of March 27, 2026, final results for the fourth quarter of 2025 have... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Stocks
    News headline image
    2 Healthcare Stocks That Could Soar Over the Next 5 Years ↗
    They could make important breakthroughs in their target markets. 
    Via The Motley Fool
    News headline image
    Global Growth Engine: Strong Trade and Production Fundamentals Propel U.S. Markets to Historic Highs
    As of March 25, 2026, the global economic landscape has shifted from the volatility of previous years into a phase of "tenuous resilience." Fueled by a significant rebound in international trade and a... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Stocks
    News headline image
    Can the "AI Supercycle" Deliver a Fourth Consecutive Double-Digit Year for the S&P 500?
    As of March 25, 2026, the S&P 500 stands at a critical crossroads. After a historic three-year run that saw the benchmark index post double-digit gains in 2023, 2024, and a robust 17.9% in 2025,... 
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy
    News headline image
    Moderna Stock is Soaring. Is It Too Late to Buy? ↗
    Moderna's full pipeline may fuel long-term growth. 
    Via The Motley Fool
    Uncover the latest developments among S&P500 stocks in today's session. ↗
    Via Chartmill
    News headline image
    2 Mooning Stocks to Target This Week and 1 We Avoid
    Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a... 
    Via StockStory
    News headline image
    Therapeutics Stocks Q4 Teardown: Moderna (NASDAQ:MRNA) Vs The Rest
    Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Pfizer vs Moderna: Which Pharma Stock Has More Upside? ↗
    They aren't just "pandemic stocks." 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery
    The biotech sector has found its new North Star in 2026. As of mid-March, Moderna Inc. (NASDAQ: MRNA) has shocked Wall Street with a staggering 83% year-to-date gain, catapulting it to the upper... 
    Via MarketMinute
    Topics Artificial Intelligence Initial Public Offering Stocks
    News headline image
    The S&P 500's 3 Best-Performing Stocks so far in 2026 ↗
    Via MarketBeat
    Topics Stocks
    News headline image
    3 Healthcare Stocks We’re Skeptical Of
    Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
    Via StockStory
    News headline image
    BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier
    In a watershed moment for the biotechnology sector, BioNTech SE (NASDAQ: BNTX) has reported its full-year 2025 financial results, signaling the definitive end of the COVID-19 vaccine gold rush and the... 
    Via MarketMinute
    Which S&P500 stocks are moving on Monday? ↗
    Via Chartmill
    News headline image
    3 Unprofitable Stocks That Concern Us
    Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Finding... 
    Via StockStory
    News headline image
    PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know
    What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea... 
    Via StockStory
    Topics Economy
    These S&P500 stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    The Moderna Pivot: Analyzing the 14% Surge and the Future of mRNA Oncology
    On March 6, 2026, Moderna, Inc. (NASDAQ: MRNA) remains the centerpiece of biotech conversations following a staggering 14% surge in its share price earlier this week. For a company that became a... 
    Via Finterra
    Topics Initial Public Offering Intellectual Property
    Explore the top gainers and losers within the S&P500 index in today's session. ↗
    Via Chartmill
    What's going on in today's session: S&P500 movers ↗
    Via Chartmill
    News headline image
    Moderna Settles High-Stakes LNP Patent War with $2.25 Billion Agreement
    In a landmark resolution that removes a multi-year shadow over the messenger RNA (mRNA) industry, Moderna, Inc. (NASDAQ:MRNA) has reached a comprehensive $2.25 billion global settlement with Genevant... 
    Via MarketMinute
    Topics Intellectual Property Lawsuit
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.